These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3340119)

  • 1. Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass.
    Salama A; Hugo F; Heinrich D; Höge R; Müller R; Kiefel V; Mueller-Eckhardt C; Bhakdi S
    N Engl J Med; 1988 Feb; 318(7):408-14. PubMed ID: 3340119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF; Koski CL; Shin ML
    J Immunol; 1985 Mar; 134(3):1804-9. PubMed ID: 3968432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.
    Bhakdi S; Käflein R; Halstensen TS; Hugo F; Preissner KT; Mollnes TE
    Clin Exp Immunol; 1988 Dec; 74(3):459-64. PubMed ID: 2466593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
    Schaefer RM; Rauterberg EW; Deppisch R; Vienken J
    Miner Electrolyte Metab; 1990; 16(1):73-6. PubMed ID: 2325595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C5b-9 assembly: average binding of one C9 molecule to C5b-8 without poly-C9 formation generates a stable transmembrane pore.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1986 Apr; 136(8):2999-3005. PubMed ID: 3958488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium.
    Schäfer H; Mathey D; Hugo F; Bhakdi S
    J Immunol; 1986 Sep; 137(6):1945-9. PubMed ID: 3528291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of terminal complement complexes in the plasma membrane of nucleated cells: influence of extracellular Ca2+ and association with cellular Ca2+.
    Carney DF; Hammer CH; Shin ML
    J Immunol; 1986 Jul; 137(1):263-70. PubMed ID: 3711667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ
    Biochim Biophys Acta; 1983 Aug; 732(3):541-52. PubMed ID: 6871214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
    Schönermark S; Filsinger S; Berger B; Hänsch GM
    Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S; Tranum-Jensen J
    J Immunol; 1984 Sep; 133(3):1453-63. PubMed ID: 6747293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell volume and osmotic properties of erythrocytes after complement lysis measured by flow cytometry.
    Bauer J; Valet G
    J Immunol; 1983 Feb; 130(2):839-44. PubMed ID: 6848597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SC5b-7, SC5b-8 and SC5b-9 complexes of complement: ultrastructure and localization of the S-protein (vitronectin) within the macromolecules.
    Preissner KP; Podack ER; Müller-Eberhard HJ
    Eur J Immunol; 1989 Jan; 19(1):69-75. PubMed ID: 2465906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failure.
    Himmelfarb J; McMonagle E; Holbrook D; Hakim R
    Kidney Int; 1999 Feb; 55(2):659-66. PubMed ID: 9987090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of complement on the lateral mobility of erythrocyte membrane proteins. Evidence for terminal complex interaction with cytoskeletal components.
    Liu ZY; Sanders ME; Hu VW
    J Immunol; 1989 Apr; 142(7):2370-6. PubMed ID: 2494258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
    Haeger M; Unander M; Bengtsson A
    Obstet Gynecol; 1990 Oct; 76(4):698-702. PubMed ID: 2216207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine and complement levels in patients undergoing cardiopulmonary bypass.
    Steinberg JB; Kapelanski DP; Olson JD; Weiler JM
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1008-16. PubMed ID: 8246532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
    Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
    J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural events associated with the attachment of complement components to cell membranes in reactive lysis.
    Dourmashkin RR
    Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between channel size and the number of C9 molecules in the C5b-9 complex.
    Ramm LE; Whitlow MB; Mayer MM
    J Immunol; 1985 Apr; 134(4):2594-9. PubMed ID: 2579147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.